Ser332
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.6.0.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser332  -  CXCR4 (mouse)

Site Information
NsMsRGssLkILSKG   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 3849622

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 ) , mutation of modification site ( 2 ) , phospho-antibody ( 2 ) , western blotting ( 2 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Regulatory protein:
CXCR4 (human) ( 2 )
Treatments:
CXCL12 ( 2 ) , EGF ( 2 ) , NKH_477 ( 2 ) , phorbol_ester ( 2 ) , staurosporine ( 2 )

References 

1

Degryse S, et al. (2017) Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia. Leukemia
28852199   Curated Info

2

Mueller W, et al. (2013) Hierarchical organization of multi-site phosphorylation at the CXCR4 C terminus. PLoS One 8, e64975
23734232   Curated Info